East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more East Resources Acquisition Charts. Click Here for more East Resources Acquisition Charts.](/p.php?pid=staticchart&s=N%5EERES&p=8&t=15)
SFBC International Selects eResearchTechnology to Provide
Integrated Suite of Software for Managing Late-Stage Drug Development Services
PHILADELPHIA and MIAMI, June 28 /PRNewswire-FirstCall/ -- eResearchTechnology,
Inc. (eRT), (NASDAQ:ERES), a leading e-research technology and services
provider, announced today that it has entered into an agreement to provide SFBC
International, Inc. (NASDAQ:SFCC), a provider of specialized drug development
services to global and specialty pharmaceutical, biotechnology and generic drug
companies, with an integrated technology and services solution that includes an
end-to-end clinical research platform, electronic data capture and a web portal
for clients' access to real-time data. Financial terms of the agreement were
not disclosed.
The integrated suite of software and technology that eRT will provide to SFBC
will include its eResearch Network, Enterprise EDC platform and eResearch
Community web portal. eRT's eResearch Network integrated suite of applications
for clinical data management, trial management and monitoring, and adverse
event management and reporting will be deployed to support development of
harmonized processes across all key aspects of clinical development for SFBC, a
rapidly expanding provider of comprehensive services for all phases of clinical
development. eRT's Enterprise EDC platform will be implemented to support
SFBC's ability to provide sponsors with an electronic data capture solution
that can scale from a single trial to an entire development program. In
addition, SFBC will deploy eRT's eResearch Community web portal for overall
command and control, real-time analysis and decision support, and collaboration
and communications across its clinical research network. SFBC anticipates that
the software implementation will commence in the third quarter of 2004 and be
completed in the first quarter of 2005.
In April 2003, the companies announced a non-exclusive alliance for providing
integrated solutions for thorough Phase I ECG studies, which monitor cardiac
safety and a drug's impact on the QTc interval. Under this alliance, SFBC
conducts thorough QTc interval trials at its Phase I/II facilities in the U.S.
and Canada, while eRT performs digital collection, measurement, interpretation,
review and distribution of cardiac safety data through its EXPeRT
workflow-enabled data handling technology.
"We are delighted to have been selected by SFBC to provide a clinical data
technology infrastructure that will support harmonization of activities across
all phases of clinical development for an expanding network of locations," said
Joe Esposito, eRT's president and chief executive officer. "This agreement to
provide eRT's Enterprise EDC, end-to-end eResearch Network, and eResearch
Community portal, in combination with the existing alliance to provide turnkey
solutions in the mission critical Thorough Phase I ECG Study arena, illustrates
eRT's unique capabilities to provide the technology and services required for
new drug development industry leaders to achieve best practices."
Dr. Gregory B. Holmes, executive vice president of clinical operations for SFBC
International, commented, "Based on the rapid growth of our business and our
business outlook, we believe it is the right time to implement a comprehensive
suite of software and services for our late-stage development business that
will enable us to enhance the level of service we currently provide to our
clients through the integration of data management, electronic data capture and
real-time data access. We selected eRT for our new software implementation
because of its user-friendly and cost-effective integrated clinical data
technology solution."
About SFBC International, Inc.
SFBC International, Inc. is a contract research organization, providing a range
of specialized drug development services to pharmaceutical, biotechnology and
generic drug companies. The company is a provider of early clinical development
services, specializing primarily in the areas of Phase I and Phase II clinical
trials and bioanalytical laboratory services. SFBC also provides a range of
complementary services to its clients, including early clinical pharmacology
research, biostatistics and data management, and regulatory and drug submission
as well as Phase III and Phase IV clinical trial management services in select
therapeutic areas. Additional information is available at the Company's
website, http://www.sfbci.com/ or contact Evan Smith or Erica Pettit, KCSA
Worldwide, at 212-682-6300.
About eResearchTechnology, Inc.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a
provider of technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a market leader in
providing centralized core-diagnostic electrocardiographic (ECG) technology and
services to evaluate cardiac safety in clinical development. The company is
also a leader in providing technology and services to streamline the clinical
trials process by enabling its customers to automate the collection, analysis,
and distribution of clinical data in all phases of clinical development.
Statements in this release including the implementation and completion of
installation of the eRT software constitute forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995. Such
statements involve a number of risks and uncertainties such as technological
development and available personnel. As a result, actual results may differ
materially from any financial outlooks stated herein. Further information on
potential factors that could affect the realization of the forward-looking
statements can be found in each company's filings with the Securities and
Exchange Commission including their Forms 10-K and 10-Q.
DATASOURCE: eResearchTechnology, Inc.; SFBC International
CONTACT: Joan Sterlacci of eResearchTechnology, +1-908-203-6473;
or Matt Hayden of Hayden Communications, +1-858-456-4533, for
eResearchTechnology; or Ana Lopez of SFBC International, +1-305-895-0304; or
Evan Smith, CFA, +1-212-896-1251, or Erica Pettit, +1-212-896-1248, both of
KCSA Worldwide
Web site: http://www.ert.com/
http://www.sfbci.com/